Detailed explanation of the anti-cancer mechanism of Doxorubicin and its application value in tumor treatment

Doxorubicin (Doxorubicin) is an anthracycline antibiotic widely used in tumor treatment and has significant anti-cancer effects. Its main mechanism of action includes DNA intercalation and topoisomerase II inhibition. Doxorubicin molecules can embed into the double helix structure of DNA and deform the helix of DNA, thereby hindering the synthesis of DNA and RNA. This effect directly inhibits the proliferation and division of cancer cells, causing breaks and damage during the replication process, ultimately leading to cell apoptosis or death.

In addition, doxorubicin can inhibit the activity of topoisomeraseII. Topoisomerase II plays a key role in DNA replication and transcription, cutting and rejoining DNA strands. Doxorubicin forms a stable complex with topoisomerase II to prevent DNA strands from reconnecting, leading to the accumulation of DNA double-strand breaks, further enhancing its anti-cancer effect. This dual mechanism makes doxorubicin highly effective in a variety of rapidly proliferating malignant tumors.

In clinical application, doxorubicin is widely used in the treatment of solid tumors and hematological tumors, such as breast cancer, ovarian cancer, lung cancer, lymphoma and leukemia. It is often used in combination with other chemotherapy drugs to improve efficacy and reduce drug resistance. For example, in adjuvant chemotherapy regimens for breast cancer, doxorubicin is often used in combination with cyclophosphamide and paclitaxel, which can significantly reduce the recurrence rate and improve the survival rate of patients. At the same time, doxorubicin can also be used in the conditioning regimen before bone marrow transplantation.

However, the application of doxorubicin requires attention to drug toxicity. Its main adverse reactions include cardiotoxicity, bone marrow suppression, nausea, vomiting, and hair loss. Long-term use of large doses may lead to irreversible myocardial damage. Therefore, it is necessary to strictly control the cumulative dose in clinical use, and regularly monitor cardiac function and blood routine. Through scientific and reasonable medication regimens, doxorubicin can exert its important value in tumor treatment while ensuring safety.

Reference materials:https://www.drugs.com/